B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ABCG2

MOLECULAR TARGET

ATP binding cassette subfamily G member 2 (JR blood group)

UniProt: Q9UNQ0NCBI Gene: 942922 compounds

ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) is targeted by 22 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ABCG2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1licochalcone3.3026
2Quercetin1.956
3Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is1.614
4Apigenin 5,7,4'-trihydroxy-flavone,1.102
5chrysin1.102
6Genistein1.102
7Kaempferols1.102
83',4'-didemethylnobiletin [Supplementary Concept]1.102
9Atorvastatin0.691
10Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
11Sirolimus0.691
12Avapritinib0.691
13candesartan cilexetil [Supplementary Concept]0.691
14Caspofungin0.691
15Daunorubicin0.691
16Delavirdine0.691
17Estrone0.691
18Febuxostat0.691
19Fenofibrate0.691
20Furosemide0.691
21Sorafenib0.691
22Topotecan0.691

About ABCG2 as a Drug Target

ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 22 compounds with documented ABCG2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ABCG2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.